Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS

Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human

Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma

Immunotherapy prospects in the treatment of lung cancer and mesothelioma

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

Dendritic cell-based immunotherapy in mesothelioma

Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma

Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma

What’s the place of immunotherapy in malignant mesothelioma treatments?

Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy